Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Chervin RD, Frey KA, Bohnen NI.

Ann Neurol. 2012 Apr;71(4):560-8. doi: 10.1002/ana.22691.

2.

Clinical markers for identifying cholinergic deficits in Parkinson's disease.

Müller ML, Bohnen NI, Kotagal V, Scott PJ, Koeppe RA, Frey KA, Albin RL.

Mov Disord. 2015 Feb;30(2):269-73. doi: 10.1002/mds.26061. Epub 2014 Nov 12.

3.

Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease.

Müller ML, Albin RL, Kotagal V, Koeppe RA, Scott PJ, Frey KA, Bohnen NI.

Brain. 2013 Nov;136(Pt 11):3282-9. doi: 10.1093/brain/awt247. Epub 2013 Sep 20.

4.

Risky driving and pedunculopontine nucleus-thalamic cholinergic denervation in Parkinson disease.

Weathers SP, Kotagal V, Bohnen NI, Chou KL.

Parkinsonism Relat Disord. 2014 Jan;20(1):13-6. doi: 10.1016/j.parkreldis.2013.08.021. Epub 2013 Sep 8.

5.

Gait speed in Parkinson disease correlates with cholinergic degeneration.

Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Scott PJ, Albin RL, Müller ML.

Neurology. 2013 Oct 29;81(18):1611-6. doi: 10.1212/WNL.0b013e3182a9f558. Epub 2013 Sep 27.

6.

Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease.

Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, Frey KA.

Brain. 2010 Jun;133(Pt 6):1747-54. doi: 10.1093/brain/awq079. Epub 2010 Apr 22.

7.

History of falls in Parkinson disease is associated with reduced cholinergic activity.

Bohnen NI, Müller ML, Koeppe RA, Studenski SA, Kilbourn MA, Frey KA, Albin RL.

Neurology. 2009 Nov 17;73(20):1670-6. doi: 10.1212/WNL.0b013e3181c1ded6.

8.

Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.

Bohnen NI, Frey KA, Studenski S, Kotagal V, Koeppe RA, Constantine GM, Scott PJ, Albin RL, Müller ML.

Mov Disord. 2014 Aug;29(9):1118-24. doi: 10.1002/mds.25929. Epub 2014 Jun 7.

9.

Rapid eye movement sleep behaviour disorder in young- and older-onset Parkinson disease: a questionnaire-based study.

Mahale R, Yadav R, Pal PK.

Sleep Med. 2014 Jun;15(6):642-6. doi: 10.1016/j.sleep.2014.01.022. Epub 2014 Mar 31.

PMID:
24780134
10.

Abnormal MoCA and normal range MMSE scores in Parkinson disease without dementia: cognitive and neurochemical correlates.

Chou KL, Lenhart A, Koeppe RA, Bohnen NI.

Parkinsonism Relat Disord. 2014 Oct;20(10):1076-80. doi: 10.1016/j.parkreldis.2014.07.008. Epub 2014 Jul 19.

11.

Heterogeneity of cholinergic denervation in Parkinson's disease without dementia.

Bohnen NI, Müller ML, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA.

J Cereb Blood Flow Metab. 2012 Aug;32(8):1609-17. doi: 10.1038/jcbfm.2012.60. Epub 2012 May 9.

12.

Relationship between (123)I-MIBG scintigrams and REM sleep behavior disorder in Parkinson's disease.

Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T, Miyoshi H, Nakashima K.

Parkinsonism Relat Disord. 2010 Dec;16(10):683-5. doi: 10.1016/j.parkreldis.2010.08.011. Epub 2010 Sep 16.

PMID:
20846893
13.

Frequency of REM sleep behavior disorders in patients with Parkinson's disease.

Janković M, Svetel M, Kostić V.

Vojnosanit Pregl. 2015 May;72(5):442-6.

PMID:
26165053
14.

Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.

Bohnen NI, Kotagal V, Müller ML, Koeppe RA, Scott PJ, Albin RL, Frey KA, Petrou M.

Parkinsonism Relat Disord. 2014 Dec;20(12):1394-8. doi: 10.1016/j.parkreldis.2014.10.008. Epub 2014 Oct 15.

15.

Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease.

Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, Frey KA.

J Cereb Blood Flow Metab. 2006 Sep;26(9):1198-212. Epub 2006 Jan 18.

PMID:
16421508
16.

Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects.

Bohnen NI, Albin RL, Müller ML, Petrou M, Kotagal V, Koeppe RA, Scott PJ, Frey KA.

JAMA Neurol. 2015 Feb;72(2):194-200. doi: 10.1001/jamaneurol.2014.2757.

PMID:
25506674
17.

Gender differences in cholinergic and dopaminergic deficits in Parkinson disease.

Kotagal V, Albin RL, Müller ML, Koeppe RA, Frey KA, Bohnen NI.

J Neural Transm (Vienna). 2013 Oct;120(10):1421-4. doi: 10.1007/s00702-013-1013-1. Epub 2013 Mar 27.

18.

Is REM sleep behaviour disorder (RBD) a risk factor of dementia in idiopathic Parkinson's disease?

Marion MH, Qurashi M, Marshall G, Foster O.

J Neurol. 2008 Feb;255(2):192-6. doi: 10.1007/s00415-008-0629-9. Epub 2008 Jan 29.

PMID:
18217187
19.

Clinical manifestations of Parkinson disease and the onset of rapid eye movement sleep behavior disorder.

Gong Y, Xiong KP, Mao CJ, Shen Y, Hu WD, Huang JY, Han F, Chen R, Liu CF.

Sleep Med. 2014 Jun;15(6):647-53. doi: 10.1016/j.sleep.2013.12.021. Epub 2014 Mar 6.

PMID:
24841108
20.

REM sleep behavior disorder and neuropathology in Parkinson's disease.

Postuma RB, Adler CH, Dugger BN, Hentz JG, Shill HA, Driver-Dunckley E, Sabbagh MN, Jacobson SA, Belden CM, Sue LI, Serrano G, Beach TG.

Mov Disord. 2015 Sep;30(10):1413-7. doi: 10.1002/mds.26347. Epub 2015 Aug 12.

PMID:
26265105

Supplemental Content

Support Center